A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2004
11/25/2004	US20040235946 Administering an allium-related organosulfur compound, results in localized thiosulfinate being non-enzymatically formed in response to localized generation of H2O2 by activated immune system cells of the host
11/25/2004	US20040235945 Combining EDTA-sodium-metal complex(es) and the sodium selenite solution to from trace element soultuton to provide the solution to the animals
11/25/2004	US20040235944 Novel pseudolaric acid-b derivatives, their preparation and pharmaceutical compositions
11/25/2004	US20040235943 Triptolide derivatives for modulation of apoptosis and immunosuppression
11/25/2004	US20040235942 administering to a patient who has previously undergone standard therapy for venous thromboembolism a low dose of warfarin
11/25/2004	US20040235941 Dimer digallate compositions
11/25/2004	US20040235940 Use of oxandrolone in the treatment of burns and other wounds
11/25/2004	US20040235939 Macrolactone having very dense functionalization; antiproliferative activity
11/25/2004	US20040235938 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
11/25/2004	US20040235936 Analgesics; anesthetics; antiinflammatory agents; central nervous system duisorders; strokes; antiarthritic agents; inflammatory bowel disorders
11/25/2004	US20040235935 A statin derivative suspended in at least an oily excipient: for releasing water free suspension in gastrointestinal system
11/25/2004	US20040235933 Administering aromatic or heteroaromatic substituted indolealkanoic acid derivataives for the treatment of chronic complications arising from diabetes mellitus e.g. diabetic cataracts, retinopathy, nephropathy and neuropathy
11/25/2004	US20040235931 Inhibition of herpes virus replication
11/25/2004	US20040235930 Indole derivatives and their use for the treatment of osteoporosis amongst other applications
11/25/2004	US20040235929 Antiestrogenic and antitumorigenic activities; cancer
11/25/2004	US20040235925 preventing a cyclooxygenase-2 mediated disorder
11/25/2004	US20040235924 antidepressants; anxiolytic agents; eating disorders; post-traumatic stress disorders; headaches;drug addition; antiinflammatory agents
11/25/2004	US20040235923 mixture of threonine, proline, glycine, valine, isoleucine, leucine, tyrosine, phenylalanine, lysine, aspartic acid, serine, glutamic acid, alanine, methionine, histidine and arginine as a unit; reduction of accumulated body fat, alleviation of excess sensitivity to cold, warming of a cold body
11/25/2004	US20040235922 Increasing the rate of apoptosis in adipose tissue cells, and reducing adipose tissue mass using catecholamines (clenbuterol, cimaterol, procaterol, terbutaline, formoterol, salmeterol, ractopamine, salbutamol)
11/25/2004	US20040235921 6-substituted 2,3-dihydro-1,4-benzodioxine, 2-position substituted with carboxy, or (C1 C6)alkoxycarbonyl; diabetes, obesity; 6-[2-(R)-[2-(S)-hydroxy-3-(4-hydroxy-3-methanesulfonamido-phenoxy)propylamino]propyl]-2,3-dihydro-1,4-benzodioxine-2-(R)-carboxylic acid; B3 andrenergic receptor agonist
11/25/2004	US20040235920 Novel use of substituted aminomethyl chromans for the treatment of movement disorders and of adverse effects induced by drugs administered to treat extrapyramidal movement disorders
11/25/2004	US20040235919 Useful in treating cell proliferative disorders associated with an altered cell cycle dependent kinase activity; cancer, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders
11/25/2004	US20040235917 Suspension, ointment, solution, spray, lotion, gel, cream, powder, powder spray, paste, emulsion, foam or stick; for treatment of herpes infections in humans
11/25/2004	US20040235916 Thiazolyl amides and their use as antiviral drugs
11/25/2004	US20040235915 Benzothiazole derivatives
11/25/2004	US20040235914 Acyclic, aromatic, heteroaromatic and cyclic ring containing amido-derivatives, useful as antibacterial agent; inhibition of formation of biofilms in personal hygiene articles, toileteries, cosmetics and in industrial settings like ship hulls, food processing systems, oil recovery or paper making plants
11/25/2004	US20040235911 hydroxyamidines; antibiotic resistance
11/25/2004	US20040235910 Mutilin derivatives and their use as antibacterials
11/25/2004	US20040235909 substituted bis/thiohydrazide amide compound; synergistic effect with taxol or taxotere, anticancer agents, side effect reduction
11/25/2004	US20040235907 Treatment of diabetes and related pathologies
11/25/2004	US20040235906 Substituted amine derivatives and their use as monoamine neurotransmitter re-up-take inhibitors
11/25/2004	US20040235905 preventing overload of Ca2+ ions in cells; ischemic heart diseases, ischemic cerebral diseases, ischemic renal diseases and in the protection of cells during thrombolytic therapy, angioplasty, bypass operation of coronary artery or organ transplantation and arrhythmias
11/25/2004	US20040235900 Antimicrobial oxazolifinones with improved pharmacokinetic profile and safety advantages
11/25/2004	US20040235899 5-halo-tryptamine derivatives used as ligands of the 5-ht6 and/or 5-ht7 serotonin receptors
11/25/2004	US20040235898 pyridinium salts such as 1-ethyl-(E,E)-2,6-bis[2-[4-(dimethylamino)phenyl]ethenyl]pyridinium chloride, used as fungicides, bactericides or insecticides on substrates
11/25/2004	US20040235897 3-[(1-benzyl-piperidin-4-yl)-(4-diethylcarbamoyl-phenyl)-amino]-benzamide used as opiod receptor agonists having improved pharmacokinetic, bioavailability, stability and/or lower toxicity; analgesisc; anxiolytic agents
11/25/2004	US20040235896 Certain azacycloalkyl substituted acetic acid derivatives
11/25/2004	US20040235894 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of asthma and/or rhinitis; respiratory system disorders
11/25/2004	US20040235892 enzyme inhibitors such as N-[4-(3-amino-1,2-benzisoxazol-4-yl)phenyl]-N'-(3-methylphenyl)urea, used for prophylaxis of cancer
11/25/2004	US20040235891 1-(2,2-diphenyl-ethyl)-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline- 2-carbaldehyde; for treating sleep disorders
11/25/2004	US20040235890 Remedies for allergic diseases
11/25/2004	US20040235889 administering imidazole, alanine, phenylalanine, substituted ethylamines, phenethylamine, histamine, histidine and linked di-imidazoles, that potentiate intraneuronal enzyme lyases; prophylaxis of neurodegenerative disorders
11/25/2004	US20040235888 Utilities of amide compounds
11/25/2004	US20040235887 Carbamates derived from arylalkylamines
11/25/2004	US20040235885 Novel composition and method for stabilizing the same
11/25/2004	US20040235884 increasing choline transporters on the cell membrane of nervous systems by administering drugs such as 2-(2-oxopyrrolidin-1-yl)-N-(2,3dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4yl)acetamide; prophylaxis of nervous system disorders
11/25/2004	US20040235883 Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders
11/25/2004	US20040235882 compounds such as (8R,9R)-2,3-Dimethyl-9-phenyl-8-pivaloyloxy-7,8,9,10-tetrahydroimidazo[1.2-h][1.7]naphthyridin-7-one, used as antisecretory agents
11/25/2004	US20040235881 Immune response modifiers for the treatment of periodontal disease
11/25/2004	US20040235880 2-(9-Chloro-3-methyl-4oxo-5H-isoxazolo[4,3-c]quinolin-5-yl)-pyridine, optionally substituted in the 6 positionof the pyridine ring; coadministering with vincristine, epirubicin, daunorubucin, doxorubicin, or etoposide to reduce the severity of MRP1 derived drug resistance
11/25/2004	US20040235879 Method for treatment of chemotherapy-induced diarrhea
11/25/2004	US20040235877 Novel use of tricyclic compound
11/25/2004	US20040235876 4,5-Disubstituted-2-aminopyrimidines
11/25/2004	US20040235873 foods and drinks, animal feeds or adjuvants comprising orotic acid and/or salts, used as antiallergens
11/25/2004	US20040235872 Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors
11/25/2004	US20040235871 A hexahydro-1,5,6,8-tetraaza-acenaphthylene or -1,3,4-triazaphenalene derivatives; treatment of depression and anxiety; inflammatory bowel disease; treatment of conditions mediated by corticotropin-releasing factor
11/25/2004	US20040235870 Protein kinase inhibitors
11/25/2004	US20040235868 Purine derivatives having, in particular, anti-proliferative properties and their biological uses
11/25/2004	US20040235866 Lymphocytic activation inhibitor and remedial agent for autoimmune disease
11/25/2004	US20040235864 Jun kinase inhibitors
11/25/2004	US20040235863 As stimulators for soluble guanylate cyclase and to their use as agents in the therapy of cardiovascular diseases, hypertonicity, thrombo-embolic diseases and ischemia, sexual dysfunction or inflammations and for the treatment of diseases of the central nervous system
11/25/2004	US20040235862 Protein kinase inhibitors
11/25/2004	US20040235861 Method of using flibanserin for neuroprotection
11/25/2004	US20040235860 Administering therapeutically effective amount of a carbostyril derivative compound for therapy of nervous system disorders
11/25/2004	US20040235859 Novel piperazine derivatives
11/25/2004	US20040235858 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
11/25/2004	US20040235856 Treatment of incontinence
11/25/2004	US20040235854 1H-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1 antagonistic activity
11/25/2004	US20040235853 Therapeutic agents useful for treating pain
11/25/2004	US20040235852 Benzofuran inhibitors of factor VIIa
11/25/2004	US20040235851 Nitrogen compounds such as 6-[4-(5-Fluoro-1H-indol-3-yl)-3,6-dihydro-2H-pyridin-1-ylmethyl]-7,8-dihydro-6H-5-oxa-1aza-phenanthrene and/or stereoisomers, used as serotonin receptor antagonists; anxiolytic agents
11/25/2004	US20040235850 Pharmaceutical compositions of varenicline
11/25/2004	US20040235849 For therapy and prophylaxis of states of pain
11/25/2004	US20040235848 Phenylalanine derivatives
11/25/2004	US20040235846 Administering substituted nicotinamides and nicotinamide analogs for therapy of disorder responsive to the induction of apoptosis in an animal; anti-cancer agents
11/25/2004	US20040235845 Use of phosphodiesterase iv inhibitors
11/25/2004	US20040235844 Imidazotriazinone derivatives as ligands for GABA receptors
11/25/2004	US20040235843 For therapy of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy
11/25/2004	US20040235842 For therapy of Alzheimer's disease, depression
11/25/2004	US20040235841 For therapy and prophylaxis of diseases and disorders associated with cyclin-dependent kinases (CDKs) activity
11/25/2004	US20040235838 Use of 2-alkoxyphenol-substituted imidazotriazinones
11/25/2004	US20040235837 Method for treating fibrotic diseases or other indications IE
11/25/2004	US20040235836 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents
11/25/2004	US20040235835 For prophylaxis of of asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis
11/25/2004	US20040235834 For therapy and prophylaxis of immunodeficiency disorders, inflammatory diseases, allergic diseases, autoimmune diseases, proliferative disorders, immunologically-mediated diseases, or respiratory disorders
11/25/2004	US20040235833 5-[(2R)-2-({(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl) phenyl]ethyl}amino) propyl]-N-(2-methoxybenzyl)-1H-indole-2-carboxamide for example; asthma, bronchitis, and emphysema; beta-2 adrenergic receptor agonists
11/25/2004	US20040235830 Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
11/25/2004	US20040235829 Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders
11/25/2004	US20040235828 For therapy and prophylaxis of thromboses, myocardial infarction, arteriosclerosis, inflammation, apoplexia, angina pectoris, restenosis after angioplasty, claudicatio intermittens, migraine, tumours, tumour diseases and/or tumour metastases
11/25/2004	US20040235827 For therapy and prophylaxis of disease or condition in a subject which disease or condition is affected by phospholipase modulation such as restenosis
11/25/2004	US20040235824 For the therapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses
11/25/2004	US20040235822 Benzazepine derivative, process for producing the same, and use
11/25/2004	US20040235821 Novel compounds
11/25/2004	US20040235818 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/25/2004	US20040235817 Crystalline forms of ertapenem sodium
11/25/2004	US20040235816 Administering compounds such as 1-benzhydryl-3-[(methylsulfonyl)(phenyl)methylene]azetidine for therapy of schizophrenia, Parkinson's disease, and Alzeimer's disease
11/25/2004	US20040235815 Vanadium compounds for treating cancer
11/25/2004	US20040235814 Administering compounds such as 1-[1-methylene-4-(bromo-methylene)phenylene]-4,8,11-tris(diethoxyphosphoryl-1,4,8,11-tetraazacyclotetra-decane to modulate a chemokine receptor
11/25/2004	US20040235813 Compounds that inhibit hsp90 and stimulate hsp70 and hsp40, useful in the prevention or treatment of diseases associated with protein aggregation and amyloid formation
11/25/2004	US20040235812 Pharmaceutical composition comprisng an aromatase inhibitor and an estrogen suitable for hormone replacement therapy for a male

1 ... 4879 4880 4881 4882 4883 4884 4885 4886 4887 4888 4889 4890 4891 4892 4893 4894 4895 4896 4897 4898 4899 ... 7860